A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published in Annals of Internal Medicine indicated.“We have developed a tool that can ...

The PLCO model may improve prediction of prostate cancer death at the point of screening. The Stockholm3 test may improve screening itself. A new prostate cancer-specific mortality (PCSM) model may ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

Breast, cervical, and prostate cancers remain the leading causes of death in Nigeria, accounting for 40 percent of all ...

As we gear up to observe World Cancer Day 2026 under the theme 'United by Unique', let's take a look at the stages of ...

The rate of young people dying from cancer is dropping across the United States, but death rates from one type of cancer have ...

An article about the importance of PSA testing for early detection and treatment of prostate cancer ...

A real-world study found Erleada reduced the risk of death compared with Nubeqa in patients with metastatic ...

A new study from Harvard School of Public Health (HSPH) and University of California, San Francisco, researchers suggests that men with prostate cancer who smoke increase their risk of prostate cancer ...